Beovu obtains DME indication in Europe
The European Commission (EC) has approved anti-VEGF therapy Beovu (brolucizumab) 6 mg for diabetic macular edema (DME), marking the therapy’s ...
Tag: European Commission
European Commission clears EssilorLuxottica’s GrandVision takeover, 350 stores to be divested
The European competition watchdog has cleared EssilorLuxottica’s acquisition of Europe’s largest retail optical chain GrandVision, on the condition that around ...
Novartis AMD drug Beovu secures European approval
European drug regulators have followed in the footsteps of their Australian and US counterparts, following the approval of Novartis’ new ...
Commission probes proposed EssilorLuxottica-GrandVision acquisition
EssilorLuxottica has reaffirmed its goal to complete the acquisition of optical retail giant GrandVision within the next 18 months following ...